Xenetic biosciences, inc. (XBIO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-1,179

-1,170

-8,900

-1,377

-1,327

-1,639

-1,812

-2,026

-1,822

4,445

-2,255

-2,918

-2,865

-391

-2,471

-47,771

-3,571

-

-

-1,125

-2,431

-4,302

-3,182

-2,758

-4,063

-82

-76

-13

15

-14

-2

-38

-29

-18

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

0

0

0

0

1

3

1

5

5

4

5

6

7

9

9

9

9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

5

3

Amortization of right of use asset

6

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of property and equipment

0

0

0

0

2

0

15

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

-124

163

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

18

15

-

-

-

-

-

-

-

-

-

Amortization of hybrid debt instrument discount

-

-

-

-

-

-

-

-

-

-

-

-

-

25

315

64

139

57

50

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

5

25

38

104

-

75

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Share-based expense

165

122

232

234

216

239

306

433

383

271

286

575

650

403

726

313

477

325

1,731

-2

147

834

246

43

388

-

-

-

-

-

-

-

-

-

Warrant-based income (expense) for services

-

-

-

-

-

-

-

-

4

-8

-22

-80

-15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant expense for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,367

-249

514

326

92

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Vendor share-based expense

0

-

-

-

17

-

-

-

17

37

37

29

31

180

-107

50

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Vendor share-based payments

0

-

-

-

17

-

-

-

17

37

37

29

31

180

-107

50

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-21

241

1,769

136

-780

-1,344

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instrument

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instrument

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-106

0

-1,584

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-1,069

-

-

-

-

-

-

-

-

-

Fee paid on disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

860

0

0

-430

-

-

-

-

-

-

-

-

-

Foreign currency translation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

309

190

-151

6

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

-

-

-

5

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-

-

-

-

-

-

-

-

-

-5,957

-42

0

3,000

3,000

0

0

0

-

-

-

-

-

-

-

-

5

7

14

88

-32

-26

-36

-28

-7

Prepaid expenses and other assets

86

-

-

-

536

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

97

-136

-126

29

258

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-

-

-

-

-

-

-69

327

51

-

-198

-399

584

-

-6

-80

43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

92

-282

-626

304

376

280

-234

-185

-204

-222

155

2

57

-2,015

575

569

-147

358

-100

504

181

707

292

-637

-840

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,359

-1,774

-1,115

-1,955

-193

-2,036

-2,664

-2,682

-3,211

-4,123

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-121

282

17

-99

38

60

53

52

17

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

3

3

3

3

3

3

3

3

Net cash used in operating activities

-1,000

-1,677

-2,416

-1,050

-1,254

-1,040

-1,668

-2,088

-1,666

4,838

-1,637

-1,987

280

-

-

-

-

-

-

-

-

-

-

-

-

-173

250

17

12

0

-1

-13

3

-1

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment

-

-

-

-

-

-

-

-

-

0

0

3

5

2

0

0

14

0

0

1

0

11

6

22

16

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

0

0

0

0

2

0

22

0

0

-

-

-

-

-

-

-

-

1

0

0

6

0

0

-0

5

-

-

-

-

-

-

-

-

-

Cash acquired from acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

43

-

-

-

-

-

-

-

-

-

Cash transferred in connection with Hive Out Agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

43

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-14

1

-0

-1

6

-11

-6

-22

-11

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

0

0

0

0

2

0

22

0

0

0

0

-3

-5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,000

0

3,500

0

3,000

100

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of promissory note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

160

0

0

0

0

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

10,000

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

101

-

-

-

-

-

-

-

-

-

Payments on loan from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

137

0

5

237

-100

100

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

3,262

0

2,900

100

0

0

-286

0

10,101

-

-

-

-

-

-

-

-

-

Net proceeds from issuance of common stock and warrants

0

0

10,722

0

2,699

0

-1,480

1,480

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

0

1

13,426

0

2,699

0

0

1,480

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

160

0

0

0

0

-

-

-

-

Net change in cash and restricted cash

-1,000

-1,676

11,010

-1,050

1,446

-1,040

-1,645

-608

-1,666

4,838

-1,637

-1,991

275

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate change on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-539

459

348

196

-9

51

-

-

-

-

-

-

-

-

-

Net change in cash, excluding restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

3,836

-28

-1,364

1,473

-1,113

944

-635

-1,570

-2,327

-2,779

-3,243

6,018

-13

-8

17

12

0

-1

21

3

-1

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest

0

0

0

0

0

0

-0

0

0

0

0

0

0

-

-

-

-

-

-

0

1

-

-

-

0

-

-

-

-

-

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Right of use assets obtained in exchange for lease liability

0

0

0

0

43

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock from cashless exercise of purchase warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of Series B preferred stock to common stock

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid in common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

157

70

75

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of warrants in connection with debt

-

-

-

-

-

-

-

-

-

-

-

-

-

0

406

0

1,701

1,626

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Recording of derivative liability in connection with debt

-

-

-

-

-

-

-

-

-

-

-

-

-

0

773

0

3,346

1,419

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of common shares issuable to accounts payable

-

-

-

-

-

-

-

-

-

0

0

0

65

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for promissory note converted in 2016

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity consideration transferred in the acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,750

-

-

-

-

-

-

-

-

-

Repurchase and cancellation of common stock in disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,750

-

-

-

-

-

-

-

-

-

Cash paid for taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0